JPRN-UMIN000020521已完成未知
The efficacy and the safety of the new long-acting insulin in patient with diabetes - The efficacy and the safety of the new long-acting insulin in patient with diabetes
Osaka Saiseikai Noe Hospital0 个研究点目标入组 100 人开始时间: 2016年1月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Contraindicated patient in the attached document of the insulin preparations Contraindicated patient in the attached document of diabetes drugs Hypoglycemic risk Serious heart trouble Severe hepatic dysfunction Severe renal dysfunction Internal secretion disease Needs the steroid dosage Patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
已完成
2 期
Assessing the safety and feasibility of depot buprenorphine in NSW custodial settingsOpioid use disorderMental Health - AddictionACTRN12618000942257SW Ministry of Health129
进行中（未招募）
不适用
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn’s DiseaseCrohns DiseaseMedDRA version: 12.1Level: LLTClassification code 10013099Term: Disease CrohnsEUCTR2010-020881-53-NLAmgen Inc195
已完成
2 期
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's DiseaseNL-OMON36733Amgen25
进行中（未招募）
1 期
Safety Study in Subjects With Crohn's DiseaseMedDRA version: 14.0Level: LLTClassification code 10013099Term: Disease CrohnsSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's DiseaseEUCTR2010-020881-53-BEAmgen Inc195
进行中（未招募）
1 期
A study of effect and safety of a new combination of drugs for chronic myeloid leukemia in chronic phase. Bosutinib is the basis treatment and patients will be randomized to receive or not to receive a long-acting low dose of Ropeginterferon.EUCTR2018-001044-54-FISt Olavs Hospital -Trondheim University Hospital212